Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-346942

Chief Development Officer sold 16,300 shares at an average $113.43 ($1,848,890)

  • Chief Development Officer acquired 16,300 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-10 Exercise or conversion : show line 1 in the form 10b5-1 +16,300 $21.65 $352,895 20,285 D
2026-08-10 Sale : show line 2 in the form 10b5-1 −11,530 $113.18 $1,304,933 8,755 D
2026-08-10 Sale : show line 3 in the form 10b5-1 −4,770 $114.04 $543,957 3,985 D
Open-market sales · 16,300 sh · avg $113.43 · $1,848,890

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-10 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −16,300 110,000 D
Loading xslF345X06/ownership.xml…